ArticlePharmacoepidemiology and drug safety2024

Comparing survival in trial- versus routine-care advanced urothelial cancer patients on immune checkpoint blockade.

Lucy S Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.